2.5/5
Weak
evidence
Performance evidence brief
Oral ATP
Some trials suggest anaerobic or repeated-sprint benefits, but bioavailability questions and industry-linked product specificity keep confidence modest.
Headline Finding
Anaerobic meta-analysis and sprint trials suggest possible benefit, but bioavailability and product specificity limit confidence.
Dose Context
Many studies use 400 mg/day or acute 400 mg dosing; product form and protocol matter.
Important Caveat
Universal energy-molecule claims overreach; evidence is limited to studied anaerobic protocols and specific products.
Source Drawer
Linked Research
- Meta-analysis Anaerobic meta-analysis
- Trial 3-minute all-out trial
- Trial Repeated sprint trial
- Trial Bioavailability trial
- Trial Dose-response trial full text
How To Read This Rating
The score reflects evidence that the supplement does its stated job. Some jobs are direct, such as strength, endurance, or recovery; others are indirect, such as sleep, mood, appetite, or health support. A real effect can still receive a cautious practical rating when dose, safety, product quality, or audience fit remain uncertain.
Spot An Evidence Issue?
Send the disputed claim, source link, and why it changes the practical verdict. Corrections that materially affect the claim, dose, caveat, or rating are prioritized.
Report a source or rating issue